Sir Steve Jackson
InvestorFounding Partner at Ahren Innovation Capital
Minnetonka, Minnesota, United States
Find your path to Sir
471 people in our graph share verified history with Sir — schools, employers, funds. One of them is your warm intro.
Glen AndersonunlockedSir: together at University of California, Berkeley (1988–1990)
×6Sir: together at University of California, Berkeley
×5Sir: together at University of Leeds
About
Sir Steve Jackson originated olaparib/Lynparza—the first marketed DNA-repair enzyme inhibitor, partnered with AstraZeneca and Merck—and combines a Cambridge professorship with part‑time CEO and early-stage operating experience.
Invests in
AI & Machine LearningBiotechClimate TechDeep TechHardwareRobotics
Experience
- Insmed Innovation UKChief Research Officercurrent2023 — presentBabraham Research Campus, UK
- Ahren Innovation CapitalFounding Partnercurrent2018 — present
- Mission Therapeutics Ltd.Founding Scientistcurrent2011 — present
- University of CambridgeProfessor of Biology (Frederick James Quick Professor)current1995 — present
- Adrestia Therapeutics Ltd.Founder and Chief Scientific Officer2018 — 2023Cambridge, United Kingdom
- The Gurdon Insititute, University of CambridgeHead of Cancer Research UK Laboratories2004 — 2022
- The Gurdon Institute, University of CambridgeGroup Leader1991 — 2022
- Mission TherapeuticsFounder and Chief Scientific Officer2010 — 2017
- KuDOS PharmaceuticalsFounder and Chief Scientific Officer1997 — 2006Cambridge, UK
Colleagues at Ahren Innovation Capital
Alice Newcombe-Ellis
Founding and General Partner at Ahren Innovation Capital
Alma Louise Donohoe
Promoter at Ahren Innovation Capital
Andy Parker
Founding Partner at Ahren Innovation Capital
Anuj Nanwani
Principal at Ahren Innovation Capital
David Novak
Advisor at Ahren Innovation Capital
Diego Alegría
Investment Analyst at Wollef Ventures
Eve Young
Head of Corporate Affairs and Branding at Tetragon Financial Group Limited
Jaime Díaz Torre
Associate at Glisco Partners
Frequently asked questions
- Who is Sir Steve Jackson?
- Sir Steve Jackson originated olaparib/Lynparza—the first marketed DNA-repair enzyme inhibitor, partnered with AstraZeneca and Merck—and combines a Cambridge professorship with part‑time CEO and early-stage operating experience.
- Where does Sir Steve Jackson work?
- Sir Steve Jackson is Founding Partner at Ahren Innovation Capital.
- What does Sir Steve Jackson invest in?
- Sir Steve Jackson invests in AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Hardware, Robotics.
- Where did Sir Steve Jackson go to school?
- Sir Steve Jackson studied at University of California, Berkeley; The University of Edinburgh (Doctor of Philosophy - PhD, Cell/Cellular and Molecular Biology); University of Leeds (BSc Hons).
Founder mafias
The University of Edinburgh mafia118
Also came through, then founded or led a company.
Martin SchrimpffMechanical Engineering with Management TechniquesFounded Kocomo +1Jeffrey ChangGraduate StudiesFounded Doblet +1James WattBachelor of Laws - LLBFounded BrewDog +1Chris Schulze-MelanderOriental StudiesFounded PROPER +1Nicolas HourcardMsc Finance & InvestmentFounded QuestDB +1Jay LipmanBachelor's degreeFounded Resilience Investments +1
+ 111 more
University of Leeds mafia50
Also came through, then founded or led a company.
Iain DukesMScFounded Viriom +1Jack AngelaBachelor of Arts (B.A.)Founded Meanderx +1John FordBSc (1st Class)Founded Metrion Biosciences +1Richard GodwinMBAFounded AlumaPowerTony KouzaridesFounded Storm TherapeuticsSteve JacksonBSc HonsFounded Mission Therapeutics
+ 43 more
Ahren Innovation Capital mafia3
Also came through, then founded or led a company.
Same school
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystScott DavisInvestor at GV (Google Ventures)
+ 1,994 more
Also attended The University of Edinburgh405
Sofia DolfeInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiKevin JohnsonInvestor at MedicxiPatrick NorrisGeneral Partner at Notion CapitalSarah MandersonLegal Director at Hoxton VenturesPolly BarnesInvestor at EQT Ventures
+ 399 more
Also attended University of Leeds233
Joseph StolermanInvestor at Index VenturesLaura CliffordTalent Director at NorthzoneJason MorrisVice President, Investor Relations at Sapphire VenturesIan MilbournGeneral Partner & COO at Notion CapitalJohn MesrieOperating Partner at Inreach VenturesPhil TomkinsonFinance & Portfolio Associate at Giant Ventures Global Llp
+ 227 more
Shared employers
Also worked at University of Cambridge285
Masha LevinVenture Partner at One Way VenturesChris WeyrerPrincipal at Vida VenturesAnnie DongInvestor at Dorm RoomFrancesco PomponiInvestor at Extantia CapitalJonathan RobinsonSenior Independent Director at EMV CapitalPhilip KalikmanAssistant Professor of Real Estate, Finance, & Economics at Joyance Partners
+ 279 more





















.png)

























